01 July 1997
Effects of somatostatin analog octreotide and some other antiproliferative agents on growth of transplantable colonic cancer in mice
Marek Pawlikowski, Katarzyna Winczyk, Gabriel Mełeń-MuchaMed Sci Monit 1997; 3(4): BR465-467 :: ID: 501323
Abstract
Effects of a long-acting somatostatin analog, octreotide (SMS), cysteamine (CSH), tripeptide colon mitosis inhibitor (CMI), and of cytostatic agent 5-fluorouracil on growth of transplantable murine colonic cancer Colon 38 were investigated. Tumor weight and bromodeoxyuridine (BrDU) incorporation into the tumoral cell nuclei were considered as indices of the tumor growth tumor growth. BrDU labelling was also evaluated in non-neoplastic colon. It was found that only the treatments with 5-FU alone and 5-FU plus SMS resulted in a statistically significant decrease of the tumor weight. In turn, a statistically significant reduction in tumor cell proliferation (measured by BrDU incorporation) was found only after simultaneous treatment with 5-FU and SMS. In contrast to the action in tumors, SMS did not enhance the 5-FU effect on cell proliferation in the non-neoplastic colon. Some tendencies towards lower tumor weights and cell proliferation indices was also observed after other treatments. This study suggests that SMS and 5-FU act synergistically on the growth of the investigated tumor.
Keywords: colonic cancer, somatostatin, octreotide, Cysteamine, colon mitosis inhibitor, 5-fluorouracil
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952